A detailed history of American Century Companies Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, American Century Companies Inc holds 2,769,818 shares of BMY stock, worth $160 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,769,818
Previous 2,593,428 6.8%
Holding current value
$160 Million
Previous $108 Million 33.08%
% of portfolio
0.09%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $7 Million - $9.13 Million
176,390 Added 6.8%
2,769,818 $143 Million
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $9.35 Million - $12.3 Million
-232,327 Reduced 8.22%
2,593,428 $108 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $53.7 Million - $60.9 Million
-1,118,653 Reduced 28.36%
2,825,755 $153 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $191 Million - $228 Million
3,944,408 New
3,944,408 $202 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $39.8 Million - $44.5 Million
-687,976 Reduced 13.44%
4,429,049 $257 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $5.2 Million - $5.78 Million
-81,694 Reduced 1.57%
5,117,025 $327 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $1.88 Million - $2.14 Million
-28,680 Reduced 0.55%
5,198,719 $360 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $22.1 Million - $26.2 Million
-322,534 Reduced 5.81%
5,227,399 $376 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $118,462 - $70 Million
911,253 Added 19.64%
5,549,933 $395 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $41.3 Million - $45.5 Million
-568,446 Reduced 10.92%
4,638,680 $357 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $14 Million - $16.8 Million
227,605 Added 4.57%
5,207,126 $380 Million
Q4 2021

Feb 07, 2022

SELL
$53.63 - $62.52 $9.99 Million - $11.6 Million
-186,339 Reduced 3.61%
4,979,521 $310 Million
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $182,835 - $214,167
-3,090 Reduced 0.06%
5,165,860 $306 Million
Q2 2021

Aug 05, 2021

SELL
$61.91 - $67.42 $13.3 Million - $14.5 Million
-215,073 Reduced 3.99%
5,168,950 $345 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $1.7 Million - $1.91 Million
-28,577 Reduced 0.53%
5,384,023 $340 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $11.8 Million - $13.4 Million
204,861 Added 3.93%
5,412,600 $336 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $15.2 Million - $16.9 Million
-265,394 Reduced 4.85%
5,207,739 $314 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $8.44 Million - $9.86 Million
153,882 Added 2.89%
5,473,133 $322 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $67.6 Million - $98.2 Million
1,456,710 Added 37.71%
5,319,251 $296 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $108 Million - $141 Million
2,198,969 Added 132.18%
3,862,541 $248 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $19.1 Million - $22.7 Million
-447,302 Reduced 21.19%
1,663,572 $84.4 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $9.27 Million - $10.3 Million
-207,756 Reduced 8.96%
2,110,874 $95.7 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $93.5 Million - $111 Million
-2,071,828 Reduced 47.19%
2,318,630 $0
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $54.9 Million - $71.2 Million
1,125,410 Added 34.47%
4,390,458 $228 Million
Q3 2018

Nov 02, 2018

BUY
$55.19 - $62.25 $16.1 Million - $18.1 Million
291,420 Added 9.8%
3,265,048 $203 Million
Q2 2018

Aug 08, 2018

BUY
$50.53 - $62.98 $33.5 Million - $41.7 Million
662,337 Added 28.66%
2,973,628 $165 Million
Q1 2018

May 03, 2018

BUY
$59.92 - $68.98 $4.62 Million - $5.32 Million
77,080 Added 3.45%
2,311,291 $146 Million
Q4 2017

Feb 02, 2018

SELL
$59.94 - $65.35 $4.19 Million - $4.57 Million
-69,912 Reduced 3.03%
2,234,211 $137 Million
Q3 2017

Nov 01, 2017

BUY
$55.23 - $63.74 $127 Million - $147 Million
2,304,123
2,304,123 $147 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.